Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation
- PMID: 35528838
- PMCID: PMC9068971
- DOI: 10.3389/fcvm.2022.864735
Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation
Abstract
Reduced blood flow velocity in the vein triggers inflammation and is associated with the release into the extracellular space of alarmins or damage-associated molecular patterns (DAMPs). These molecules include extracellular nucleic acids, extracellular purinergic nucleotides (ATP, ADP), cytokines and extracellular HMGB1. They are recognized as a danger signal by immune cells, platelets and endothelial cells. Hence, endothelial cells are capable of sensing environmental cues through a wide variety of receptors expressed at the plasma membrane. The endothelium is then responding by expressing pro-coagulant proteins, including tissue factor, and inflammatory molecules such as cytokines and chemokines involved in the recruitment and activation of platelets and leukocytes. This ultimately leads to thrombosis, which is an active pro-inflammatory process, tightly regulated, that needs to be properly resolved to avoid further vascular damages. These mechanisms are often dysregulated, which promote fibrinolysis defects, activation of the immune system and irreversible vascular damages further contributing to thrombotic and inflammatory processes. The concept of thrombo-inflammation is now widely used to describe the complex interactions between the coagulation and inflammation in various cardiovascular diseases. In endothelial cells, activating signals converge to multiple intracellular pathways leading to phenotypical changes turning them into inflammatory-like cells. Accumulating evidence suggest that endothelial to mesenchymal transition (EndMT) may be a major mechanism of endothelial dysfunction induced during inflammation and thrombosis. EndMT is a biological process where endothelial cells lose their endothelial characteristics and acquire mesenchymal markers and functions. Endothelial dysfunction might play a central role in orchestrating and amplifying thrombo-inflammation thought induction of EndMT processes. Mechanisms regulating endothelial dysfunction have been only partially uncovered in the context of thrombotic diseases. In the present review, we focus on the importance of the endothelial phenotype and discuss how endothelial plasticity may regulate the interplay between thrombosis and inflammation. We discuss how the endothelial cells are sensing and responding to environmental cues and contribute to thrombo-inflammation with a particular focus on venous thromboembolism (VTE). A better understanding of the precise mechanisms involved and the specific role of endothelial cells is needed to characterize VTE incidence and address the risk of recurrent VTE and its sequelae.
Keywords: endothelial cell; endothelial plasticity; fibrosis; inflammation; venous thromboembolism.
Copyright © 2022 Pilard, Ollivier, Gourdou-Latyszenok, Couturaud and Lemarié.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions.Cytokine Growth Factor Rev. 2017 Feb;33:41-54. doi: 10.1016/j.cytogfr.2016.09.002. Epub 2016 Sep 23. Cytokine Growth Factor Rev. 2017. PMID: 27692608 Review.
-
Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction.Front Immunol. 2018 Feb 20;9:294. doi: 10.3389/fimmu.2018.00294. eCollection 2018. Front Immunol. 2018. PMID: 29515588 Free PMC article. Review.
-
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis.Front Immunol. 2019 Feb 4;10:85. doi: 10.3389/fimmu.2019.00085. eCollection 2019. Front Immunol. 2019. PMID: 30778349 Free PMC article. Review.
-
Thrombosis and Inflammation-A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C.Front Cardiovasc Med. 2022 Mar 31;9:866751. doi: 10.3389/fcvm.2022.866751. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35433860 Free PMC article. Review.
-
Fibrinolysis and Inflammation in Venous Thrombus Resolution.Front Immunol. 2019 Jun 14;10:1348. doi: 10.3389/fimmu.2019.01348. eCollection 2019. Front Immunol. 2019. PMID: 31258531 Free PMC article. Review.
Cited by
-
Decoding Pulmonary Embolism: Pathophysiology, Diagnosis, and Treatment.Biomedicines. 2024 Aug 23;12(9):1936. doi: 10.3390/biomedicines12091936. Biomedicines. 2024. PMID: 39335450 Free PMC article. Review.
-
Understanding Cardiovascular Events With JAK Inhibitors: Tofacitinib Reduces Synovial and Vascular Inflammation but not the Prothrombotic Effects of Inflammatory Cytokines on Endothelium.ACR Open Rheumatol. 2025 Jan;7(1):e11790. doi: 10.1002/acr2.11790. ACR Open Rheumatol. 2025. PMID: 39800890 Free PMC article.
-
Advanced Research in the Pathophysiology of Venous Thromboembolism-Acute Pulmonary Embolism.Biomedicines. 2025 Apr 8;13(4):906. doi: 10.3390/biomedicines13040906. Biomedicines. 2025. PMID: 40299499 Free PMC article. Review.
-
Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions.Front Immunol. 2023 Nov 24;14:1264889. doi: 10.3389/fimmu.2023.1264889. eCollection 2023. Front Immunol. 2023. PMID: 38077393 Free PMC article. Review.
-
Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect.Front Cardiovasc Med. 2022 Aug 22;9:965726. doi: 10.3389/fcvm.2022.965726. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36072862 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources